Magipics has created an animation for Racura Oncology, a clinical biopharmaceutical company with a mission to silence cancer.
![]()
The animation describes a novel therapeutic approach to target MYC-driven cancers using Racura Oncology’s (E,E)-bisantrene drug. The drug has been shown in preclinical studies to bind and stabilise a normally unstable G-quadruplex. By locking this structure in place, (E,E)-bisantrene is believed to silence MYC transcription, evidenced through suppressed MYC mRNA levels in preclinical studies.
This mechanism represents a novel therapeutic approach being investigated by Racura Oncology to target MYC-driven cancers, with the potential to improve patient outcomes.
Click on the image below to view the animation.


Magipics has produced a biomedical animation for the PeterMacCallum Cancer Centre. The animation describes the principles of PSMA Theranostics or ProsTIC, a treatment method for Prostate cancer. Briefly, this method involves targeting Prostate Specific Membrane Antigen (PSMA), a unique marker found on the surface of prostate cancer cells. Utilizing radioactive particles conjugated to a molecule that binds only to PSMA, the cancer cells can be detected and destroyed.